Market Place
Sourcing Support
Sareum receives approval to commence SDC-1801 trial in Australia
05 May 2023 //
CLINICAL TRIALS ARENA
Sareum submits Trial Authorisation appln to MHRA for development of SDC-1801
28 Jul 2022 //
GLOBENEWSWIRE
Sareum to Present at BioTrinity 2022 Conference
26 Apr 2022 //
PRESS RELEASE
Sareum notes proposed acquisition of Sierra Oncology by GSK
13 Apr 2022 //
PRESS RELEASE
European Patent Granted for Sareum’s SDC-1802 for T-ALL
11 Apr 2022 //
PRESS RELEASE
Subscription to raise approximately £1.63 million to progress TYK2/JAK1
17 Dec 2021 //
SAREUM
Sareum Holdings` Stock Climbs On US Patent For SDC-1802 TYK2/JAK1 Inhibitor
07 Oct 2021 //
RTTNEWS
US Patent Granted for SDC-1802 TYK2/JAK1 Inhibitor
07 Oct 2021 //
INVESTEGATE
Sareum Formally Awarded Grant Funding from the UK Government (UKRI)
04 Dec 2020 //
SAREUM
US Patent Allowance for Sareum’s SDC-1802 TYK2/JAK1 Inhibitor
08 Oct 2020 //
PRESSRELEASE
Encouraging Preclinical Results Generated with Sareum’s TYK2/JAK1 Inhibitors
24 Jul 2020 //
PHARMIWEB
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.